Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
about
Current status of PAF antagonists.Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonistsInvolvement of inflammatory mediators in the airway responses to trimellitic anhydride in sensitized guinea-pigs.Mechanisms of platelet activating factor-induced changes in sheep tracheal blood flowQuantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykininBradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factorPlatelet activating factor and asthma.Preclinical and clinical pharmacology of platelet-activating factor receptor antagonists.Hetrazepines as antagonists of platelet activating factor.Mechanisms of increased airway microvascular permeability: role in airway inflammation and obstruction.Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.Mechanism of platelet activating factor-induced vascular leakage in the rat trachea.Role of PAF in the late airway microvascular leakage induced by antigen in IgE-sensitized rat.Effects of platelet-activating factor on vascular permeability and granulocyte recruitment in the rat trachea.
P2860
Q35609542-4233069A-0558-4AA8-8E4F-EFA46521E87BQ35756438-02E21510-232A-4C1A-9B1B-3D026213B832Q35870899-50A19AD2-C043-4438-8588-25E9F6058C59Q35871174-7630AA24-A045-4252-A05F-70E6B7EEC36EQ35871902-9C808FDC-FF42-4453-B38A-3F411DA41E1EQ35888369-2FE5A400-1859-4256-949D-0853B2E4E1BEQ36440019-5AF86EAA-8DA0-4FAA-B432-6508C4F0275CQ37885574-73B39ADE-C44F-48A3-AE01-8AB39E2A6FFBQ38627145-3B8B2B9E-1F6E-4760-BDAB-527366212EEBQ40959012-98A1EDDA-ECC6-4532-B02C-445CA6F735FBQ42084217-603C8804-F71C-4B14-BCF7-A1BE3A97C8F6Q42704555-644699F6-BBEC-4A3D-838F-E1ECDFF563F3Q42847887-D222B00A-4F32-4C85-AEF0-9E2C76F2567FQ43227529-E8AE8B2B-DB46-460A-A308-A18D9647B5F1Q46228069-E842A39A-CEE7-4C3F-83F4-0CB3E5AF3FA9Q50765321-9CDB99BE-52FC-4A1E-8402-C950B75C49A4Q50876423-1ECBE4B1-58A2-4DC3-9F9F-785443905F79
P2860
Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Effect of a Paf antagonist, WE ...... d platelet aggregation in man.
@en
Effect of a Paf antagonist, WE ...... d platelet aggregation in man.
@nl
type
label
Effect of a Paf antagonist, WE ...... d platelet aggregation in man.
@en
Effect of a Paf antagonist, WE ...... d platelet aggregation in man.
@nl
prefLabel
Effect of a Paf antagonist, WE ...... d platelet aggregation in man.
@en
Effect of a Paf antagonist, WE ...... d platelet aggregation in man.
@nl
P2093
P2860
P1476
Effect of a Paf antagonist, WE ...... d platelet aggregation in man.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1988.TB11511.X
P407
P577
1988-05-01T00:00:00Z